🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The University of Michigan is conducting a study investigating a potential ...
Status
Completed
Location
University of Michigan
Start Date
2006-04
Trial ID
NCT00805805
Treatments Being Tested
Surgery has been the standard of care for esophageal cancer for many years,...
Status
Completed
Location
University of Michigan Cancer Center
Start Date
2001-11
Trial ID
NCT00176800
Treatments Being Tested
This study will evaluate the safety of the administration of a copper chela...
Status
Completed
Location
University of Michigan Health System
Start Date
2003-03
Trial ID
NCT00189176
Treatments Being Tested
There are two parts to this study. It is a phase 1b followed by a randomize...
Status
Recruiting
Location
Indiana University Simon Cancer Center
Start Date
2024-11-26
Trial ID
NCT06134375
Treatments Being Tested
The main objective of this study is to determine recommended phase II dose ...
Status
Completed
Location
University of Rochester
Start Date
2013-11
Trial ID
NCT01837329
Treatments Being Tested
Psoriasis is a common skin disease affecting an estimated 2.6% of the US po...
Status
Completed
Location
University of Michigan Department of Dermatology
Start Date
2004-06
Trial ID
NCT00113542
Treatments Being Tested
This study will examine an investigational (experimental) agent Tetrathiomo...
Status
Completed
Location
University of Michigan Cancer Center
Start Date
2001-02
Trial ID
NCT00176774
Treatments Being Tested
RATIONALE: Ammonium tetrathiomolybdate may stop the growth of non-small cel...
Status
Withdrawn
Location
Roswell Park Cancer Institute
Start Date
2007-05
Trial ID
NCT00560495
Patients with moderate to high risk primary breast cancer (Stage II with mo...
Status
Terminated
Location
Memorial Sloan Kettering Cancer Center
Start Date
2003-12
Trial ID
NCT00195091
Treatments Being Tested